Aura Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	428	339	308	496	-	-
Market Cap Growth	10.78%	10.05%	-37.90%	-	-	-
Enterprise Value	246	132	140	348	-17	-32
PE Ratio	-	-4.44	-5.24	-10.74	-	-
PB Ratio	2.06	1.50	1.58	3.26	-	-
P/FCF Ratio	-5.35	-5.25	-5.53	-14.36	-	-
P/OCF Ratio	-5.41	-5.31	-5.64	-15.30	-	-
EV/EBITDA Ratio	-2.73	-1.81	-2.47	-7.67	0.81	1.37
EV/EBIT Ratio	-2.61	-1.74	-2.38	-7.53	0.78	1.34
EV/FCF Ratio	-2.83	-2.05	-2.51	-10.07	0.69	1.42
Debt / Equity Ratio	0.09	0.09	0.11	0.01	-	0.00
Debt / EBITDA Ratio	-0.26	-0.27	-0.37	-0.02	-	0.00
Debt / FCF Ratio	-0.27	-0.30	-0.37	-0.03	-	0.00
Quick Ratio	20.99	18.30	18.06	20.27	6.54	5.28
Current Ratio	21.97	18.76	18.81	20.90	6.94	5.42
Interest Coverage	-	-	-	-	-	-4839.00
Return on Equity (ROE)	-41.80%	-42.20%	-40.50%	-211.90%	30.70%	-
Return on Assets (ROA)	-36.50%	-36.70%	-36.20%	-50.70%	-101.90%	-
Return on Capital (ROIC)	-38.52%	-34.63%	-27.86%	-23.00%	20.43%	27.63%
Earnings Yield	-18.31%	-22.54%	-19.08%	-9.31%	-	-
FCF Yield	-16.90%	-19.04%	-18.08%	-6.96%	-	-
Buyback Yield / Dilution	-30.88%	-32.34%	-480.18%	-1305.21%	92.08%	-
Total Shareholder Return	-30.88%	-32.34%	-480.18%	-1305.21%	92.08%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).